Healthcare of Ontario Pension Plan Trust Fund Reduces Stock Holdings in SPDR S&P Biotech ETF $XBI

Healthcare of Ontario Pension Plan Trust Fund reduced its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 22.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,745,500 shares of the exchange traded fund’s stock after selling 2,847,000 shares during the quarter. SPDR S&P Biotech ETF accounts for approximately 2.0% of Healthcare of Ontario Pension Plan Trust Fund’s investment portfolio, making the stock its 9th biggest holding. Healthcare of Ontario Pension Plan Trust Fund owned approximately 15.28% of SPDR S&P Biotech ETF worth $1,244,793,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Financial Life Planners acquired a new stake in SPDR S&P Biotech ETF in the 1st quarter valued at about $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in SPDR S&P Biotech ETF during the fourth quarter worth about $27,000. Intesa Sanpaolo Wealth Management acquired a new position in SPDR S&P Biotech ETF during the fourth quarter worth approximately $30,000. SHP Wealth Management acquired a new position in SPDR S&P Biotech ETF during the fourth quarter worth approximately $31,000. Finally, Legacy Wealth Managment LLC ID bought a new stake in SPDR S&P Biotech ETF in the fourth quarter valued at approximately $32,000.

SPDR S&P Biotech ETF Stock Down 1.1%

NYSEARCA:XBI opened at $150.48 on Friday. SPDR S&P Biotech ETF has a 12-month low of $84.39 and a 12-month high of $165.71. The firm has a market capitalization of $10.30 billion, a price-to-earnings ratio of 11.47 and a beta of 0.82. The stock’s 50 day moving average price is $144.24 and its two-hundred day moving average price is $133.44.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.